BORTOLOTTI, FLAVIA
 Distribuzione geografica
Continente #
NA - Nord America 4.334
AS - Asia 1.295
EU - Europa 848
AF - Africa 276
SA - Sud America 256
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 13
Totale 7.047
Nazione #
US - Stati Uniti d'America 4.210
SG - Singapore 456
CN - Cina 305
HK - Hong Kong 222
BR - Brasile 163
FI - Finlandia 134
DE - Germania 110
PL - Polonia 85
SE - Svezia 81
FR - Francia 49
RU - Federazione Russa 40
GB - Regno Unito 38
IT - Italia 37
UA - Ucraina 37
VN - Vietnam 32
IN - India 23
IE - Irlanda 22
NL - Olanda 21
AR - Argentina 19
IQ - Iraq 18
LC - Santa Lucia 14
TR - Turchia 14
AE - Emirati Arabi Uniti 13
CG - Congo 13
CZ - Repubblica Ceca 13
ZA - Sudafrica 13
EC - Ecuador 12
KZ - Kazakistan 12
MA - Marocco 12
ME - Montenegro 12
PK - Pakistan 12
SK - Slovacchia (Repubblica Slovacca) 12
TN - Tunisia 12
EG - Egitto 11
GE - Georgia 11
GT - Guatemala 11
MN - Mongolia 11
MW - Malawi 11
EE - Estonia 10
ES - Italia 10
MR - Mauritania 10
MX - Messico 10
PE - Perù 10
SA - Arabia Saudita 10
TT - Trinidad e Tobago 10
UZ - Uzbekistan 10
CI - Costa d'Avorio 9
CY - Cipro 9
DK - Danimarca 9
GM - Gambi 9
JP - Giappone 9
PY - Paraguay 9
UY - Uruguay 9
BA - Bosnia-Erzegovina 8
BB - Barbados 8
BF - Burkina Faso 8
CL - Cile 8
DJ - Gibuti 8
LB - Libano 8
LV - Lettonia 8
MZ - Mozambico 8
PH - Filippine 8
UG - Uganda 8
AL - Albania 7
AO - Angola 7
AT - Austria 7
AU - Australia 7
BD - Bangladesh 7
BJ - Benin 7
BW - Botswana 7
CA - Canada 7
CH - Svizzera 7
GF - Guiana Francese 7
GN - Guinea 7
HU - Ungheria 7
IL - Israele 7
KE - Kenya 7
KH - Cambogia 7
MG - Madagascar 7
NG - Nigeria 7
PA - Panama 7
RO - Romania 7
SI - Slovenia 7
TW - Taiwan 7
VE - Venezuela 7
AF - Afghanistan, Repubblica islamica di 6
AM - Armenia 6
BE - Belgio 6
BG - Bulgaria 6
BO - Bolivia 6
BY - Bielorussia 6
CM - Camerun 6
CO - Colombia 6
CU - Cuba 6
CW - ???statistics.table.value.countryCode.CW??? 6
DZ - Algeria 6
GR - Grecia 6
HR - Croazia 6
IR - Iran 6
IS - Islanda 6
Totale 6.788
Città #
Fairfield 578
Chandler 397
Woodbridge 378
Houston 329
Singapore 316
Jacksonville 270
Wilmington 245
Ashburn 239
Hong Kong 219
Seattle 210
Cambridge 199
Santa Clara 178
Ann Arbor 168
Princeton 101
Boardman 94
Beijing 83
Bytom 70
Nanjing 65
Roxbury 52
Medford 51
Helsinki 49
San Diego 49
Des Moines 28
Los Angeles 22
Dublin 21
São Paulo 20
Buffalo 17
Munich 17
Hebei 16
Changsha 15
Redwood City 15
Castries 14
Hefei 12
Jiaxing 12
Nanchang 12
Norwalk 12
Podgorica 11
Shenyang 11
Guangzhou 10
Ho Chi Minh City 10
London 10
Brazzaville 9
Lilongwe 9
Montevideo 9
Nouakchott 9
Tallinn 9
Tashkent 9
Ulan Bator 9
Abidjan 8
Kampala 8
New York 8
Turku 8
Warsaw 8
Brooklyn 7
Cape Town 7
Conakry 7
Cotonou 7
Djibouti 7
Falkenstein 7
Luanda 7
Phnom Penh 7
Riga 7
Stockholm 7
Tbilisi 7
Abu Dhabi 6
Antananarivo 6
Banjul 6
Bridgetown 6
Cayenne 6
Falls Church 6
Guatemala City 6
Lima 6
Panama City 6
Prague 6
Rio de Janeiro 6
San Francisco 6
Willemstad 6
Yerevan 6
Astana 5
Asunción 5
Baghdad 5
Belize City 5
Belo Horizonte 5
Bishkek 5
Cairo 5
Charlotte 5
Dallas 5
Dong Ket 5
Erbil 5
Gaborone 5
Guayaquil 5
Hanoi 5
Havana 5
Istanbul 5
Mamoudzou 5
Nairobi 5
Nassau 5
Niamey 5
Ouagadougou 5
Port Moresby 5
Totale 4.999
Nome #
Liver steatosis in children with chronic hepatitis C 159
ANTIBODY TO THE POLYALBUMIN (pHSA) RECEPTOR ON HEPATITIS B VIRUS IN ACUTE INFECTION AND IN VACCINE RECIPIENTS 156
Progression of fibrosis in chronic hepatitis C in children 144
LONG-TERM OUTCOME OF CHRONIC TYPE-B HEPATITIS IN PATIENTS WHO ACQUIRE HEPATITIS-B VIRUS-INFECTION IN CHILDHOOD 142
Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children 129
Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time? 129
A 7 year survey of acute hepatitis type B. 118
Chronic viral hepatitis in children: any role for the pathologist? 117
Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis 117
Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children 116
Long-term outcome of hepatitis C in children 116
Reversal of liver cirrhosis: a desirable clinical outcome and its pathogenic background. 112
Interferon treatment in children with chronic hepatitis C: Long-lasting remission in responders, and risk for disease progression in non-responders 112
CHARACTERIZATION OF LIVER HBV-DNA FORMS ASSOCIATED WITH HBeAg TO ANTI-HBe SEROCONVERSION 112
Changes in hepatitis Be antigen/antibody system in children with chronic hepatitis B virus infection. 112
Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome 111
Chronic evolution of acute hepatitis type B: prevalence and predictive markers 108
Serum hepatitis B virus DNA in acute hepatitis type B 108
The changing epidemiology of acute type B hepatitis: results of an 11-year prospective study in Padua (northern Italy). 107
Virologic features of chronic hepatitis B virus infection in childhood. 107
Pathology of hepatitis C in childhood. 107
PREDICTIVE MARKERS OF CHRONICITY IN ACUTE HEPATITIS TYPE B 105
HEPATITIS C VIRUS GENOTYPES IN CHRONIC HEPATITIS C OF CHILDREN 104
NATURAL KILLER ACTIVITY IN PATIENTS WITH ACUTE VIRAL HEPATITIS 103
Viral Hepatitis: Treating hepatitis C in children: an open horizon. 103
Chronic hepatitis type B in childhood: longitudinal study of 35 cases. 103
BIOLOGIA MOLECOLARE APPLICATA AL VIRUS DELL'EPATITE B. STUDIO DEL DNA VIRALE NEL SIERO E NEL FEGATO E CORRELAZIONE CLINICA 103
Detection by immunofluorescence of an antigen-antibody system in patients with acute and chronic non-A, non-B hepatitis. 102
Chronic hepatitis in childhood: the spectrum of the disease. 102
Antibodies to hepatitis C virus in community-acquired acute non-A, non-B hepatitis. 101
Prognostic value of hepatitis B core antigen (HBcAg) expression in the liver of children with chronic hepatitis type B. 101
ALTERAZIONI DELL'ATTIVITA' NATURAL KILLER IN CORSO DI INFEZIONE DA VIRUS EPATITICI 100
Spontaneous regression of hepatitis B virus-associated cirrhosis developed in childhood 99
T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis b virus infection. 98
EVOLUTION OF CHRONIC HEPATITIS B OF CHILDREN TOWARDS A "HEALTHY" HBsAg CARRIER STATE : RESULTS OF A PROSPECTIVE STUDY 97
Recombinant interferon-alfa therapy in children with chronic hepatitis C. 97
Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. 96
Monitoring SCCA-IgM complex predicts liver disease progression in patients with chronic hepatitis and cirrhosis 96
Virus replication and liver disease in chronic hepatitis B virus infection. 95
ANTIGENE CORE NEL SIERO .DETERMINAZIONE E SIGNIFICATO IN PAZIENTI CON INFEZIONE ACUTA E CRONICA DA VIRUS DELL'EPATITE B 94
Different mechanisms responsible for in vitro cell-mediated cytotoxicity to autologous hepatocytes in children with autoimmune and HBsAg-positive chronic liver disease. 93
Cryptogenic chronic liver disease and hepatitis C virus infection in children. 93
Long-term persistence of hepatitis B virus DNA in the serum of children with chronic hepatitis B after hepatitis B e antigen to antibody seroconversion. 92
DETECTION OF HIDDEN HEPATITIS B CORE ANTIGEN (HBcAg) IN SERUM IN ACUTE AND CHRONIC HEPATITIS B VIRUS (HBV) INFECTION 92
HIDDEN HEPATITIS B CORE ANTIGEN (HBcAg) IN SERUM OF PATIENTS WITH ACUTE AND CHRONIC HEPATITIS B VIRUS (HBV) INFECTION 90
VIRUS RECEPTORS FOR POLYMERIZED HUMAN SERUM ALBUMIN (PHSA) IN HEPATITIS B VIRUS (HBV) INFECTION: DETECTION BY A SOLID PHASE RADIOIMMUNOASSAY (RIA) 89
Natural killer activity in patients with acute viral hepatitis 86
[Infection due to hepatitis B virus and host immune response]. 86
Prognosis of chronic hepatitis B transmitted from HBsAg positive mothers. 84
IgM antibody to hepatitis B core antigen in children with chronic type B hepatitis. 84
Selection of a precore mutant of hepatitis B virus and reactivation of chronic hepatitis B acquired in childhood. 83
Hepatitis C 82
COMPORTAMENTO DI SCCA-IgM NEL SIERO DI BAMBINI HBeAg POSITIVI SEGUITI NEL TEMPO 82
LONG-TERM COURSE OF CHRONIC HEPATITIS C IN CHILDREN: FROM VIRAL CLEARANCE TO END-STAGE LIVER DISEASE. IF 11.673 82
RECEPTORS FOR POLYMERIZED HUMAN SERUM ALBUMIN (pHSA) ON HEPATITIS B VIRUS (HBV) AND ANTI-RECEPTOR ANTIBODY IN HBV INFECTION 81
STATE OF LIVER HBV-DNA IN CHRONIC INFECTION : RELATION TO HBeAg/anti-HBe SYSTEM 81
CLINICAL RELEVANCE OF SERUM HBV-DNA TESTING IN PATIENTS WITH HBeAg POSITIVE INFECTION 81
Hepatitis C virus infection in hemodialyzed patients detected by first and second generation assays. 81
DIFFERENTI COMPORTAMENTI DELLE ALT NELL'EPATITE CRONICA B 80
[Humoral and cellular immunoreactions against HBsAg and liver-specific proteins in the course of acute and chronic hepatitis]. 79
HBV-DNA NEL SIERO: RAPPORTI CON IL PROFILO SIEROLOGICO ED EVOLUTIVO IN CORSO DI INFEZIONE 78
HIDDEN HEPATITIS B CORE ANTIGEN (HBcAg) IN SERUM IN HEPATITIS B VIRUS (HBV) INFECTION. RELATION TO LIVER DAMAGE 78
Long-term evolution of chronic hepatitis B in children with antibody to hepatitis B e antigen. 76
Histology and virus replication in the liver: a prognostic puzzle in chronic hepatitis B. 75
Hepatitis B in children. 71
[Liver-specific proteins and autoimmunity in inflammatory liver diseases]. 71
The natural history of post-transfusion and sporadic non-A, non-B, hepatitis in Italy. 67
Circulating hepatocyte membrane-specific autoantibodies in chronic active hepatitis type B. Relation to virus replication activity and liver cell necrosis. 66
Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B. 66
Favorable outcome in chronic active hepatitis caused by B virus in childhood. 65
HEPATITIS B VIRUS DNA FORMS IN THE LIVER OF CHRONICALLY INFECTED INDIVIDUALS: RELATION TO REPLICATION PROFILE 55
Low prevalence of antibodies to hepatitis C virus in hospital employees 51
Interferon tratment of chronic hepatitis C in patients cured of pediatrics malignancies. 49
Definition of hepatitis B virus (HBV)-specific target antigens recognized by cytotoxic T cells in acute HBV infection. 47
Totale 7.054
Categoria #
all - tutte 23.427
article - articoli 21.758
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 219
Totale 45.404


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021377 0 0 7 29 19 58 10 54 80 41 52 27
2021/2022853 13 96 98 64 30 62 33 97 40 13 106 201
2022/2023726 160 89 21 73 107 111 1 46 80 6 24 8
2023/2024208 4 40 33 20 10 11 3 3 5 3 24 52
2024/20251.487 7 130 48 69 310 31 92 76 69 32 269 354
2025/20261.201 118 428 655 0 0 0 0 0 0 0 0 0
Totale 7.054